HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$0.83
Day range
$0.78 - $0.83
Year range
$0.54 - $1.38
Market cap
61.14M USD
Avg Volume
405.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.68M | -24.20% |
Operating expense | 5.70M | -19.97% |
Net income | -27.89M | -27.44% |
Net profit margin | -1.04K | -68.13% |
Earnings per share | -0.22 | 56.86% |
EBITDA | -24.88M | -12.27% |
Effective tax rate | 0.11% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 135.70M | 7.85% |
Total assets | 151.53M | 3.30% |
Total liabilities | 59.45M | 38.92% |
Total equity | 92.08M | — |
Shares outstanding | 75.67M | — |
Price to book | 0.67 | — |
Return on assets | -53.23% | — |
Return on capital | -74.41% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -27.89M | -27.44% |
Cash from operations | -22.66M | -35.01% |
Cash from investing | -7.00K | -100.06% |
Cash from financing | 87.94M | 72,574.38% |
Net change in cash | 65.27M | 1,390.45% |
Free cash flow | -12.16M | -68.11% |
About
Founded
2018
Headquarters
Website
Employees
66